QIPT - Quipt Home Medical: Acquisitions And Earnings Breathe Life Back Into Shares

• QIPT shares have recovered from their warrant overhang lows, but still have plenty of room to run, with a triple possible within 3 years.
• The company recently completed two more sets of smaller acquisitions, the benefit of which the market does not seem to fully appreciate.
• With the work associated with a Nasdaq uplisting behind them and the impressive hire of a key executive, the company is set to execute on its M&A pipeline.
• Absent any additional growth via acquisition, the company is significantly undervalued based on my EBITDA run rate calculations.
• Investor concern over a possible capital raise to fund acquisitions is likely overblown, with plenty of cash on hand and access to inexpensive debt.

For further details see: